Back to Trials
NCT03125655RecruitingAccepts Healthy Volunteers

Regulation of Inflammatory Genes in Psoriasis

University of Alabama at Birmingham

Start Date

4/22/2014

Completion Date

4/28/2028

Summary

Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.

Eligibility Criteria

Age Range: 19 years to 99 years

Inclusion Criteria: * Clinical diagnosis of psoriasis * Must be age 19 or older. * Must be Fitzpatrick skin type I, II, III, IV, V, VI. Exclusion Criteria: * Subjects who do not have photosensitive disease and are not on photosensitizing medications. * Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy). * Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants. * Subjects who are pregnant.

Interventions

DIAGNOSTIC_TEST

Inflammatory markers

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

PsoriasisInflammation

Locations

The Kirklin Clinic

Birmingham, Alabama 35294

United States